Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENXG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,881
Award facts
- Contract value 100% obligated
- $4,880.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $4,880.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 26, 2025, represents one of multiple orders placed under DMS Pharmaceutical Group's recently awarded Indefinite Delivery Contract (IDC) with the DLA under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying IDC, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations worldwide. No set-aside designation applies to this delivery order, demonstrating the contractor's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group is positioned as a critical regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy, which supports military healthcare facilities globally. The company's product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, specialty pharmaceuticals, and routine drugs spanning multiple therapeutic categories. As the sole prime contractor on this delivery order with no identified subcontractors, DMS Pharmaceutical Group has demonstrated substantial performance capability through numerous prior delivery orders issued by the DLA's Medical Supply Chain division, with awards previously ranging from under $100 to over $115,000, establishing the company's established track record within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DU26FENXG?
SPE2DU26FENXG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DU26FENXG worth?
The government has obligated $4,881 on SPE2DU26FENXG.
Is contract SPE2DU26FENXG an order under another contract?
Yes. SPE2DU26FENXG is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENXG competed?
The extent of competition for SPE2DU26FENXG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award